| Financial Year |
March 31 2023 |
| Monetary Funds |
787,308,203.43 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
32,150,000.00 |
| Accounts Receivable |
501,382,317.04 |
| Advances to Suppliers |
213,416,697.52 |
| Other Receivables |
100,453,289.41 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
405,260,935.46 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
52,997,026.38 |
| Total Current Assets |
2,092,968,469.24 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
89,219,710.40 |
| Investment Properties |
303,440,748.02 |
| Fixed Assetes |
857,716,840.70 |
| Under-construction Projects |
231,616,454.88 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
155,900,175.89 |
| R&D expenses |
832,134.52 |
| Goodwill |
13,000,000.00 |
| Long-Term Deferred and Prepaid Expenses |
9,096,903.38 |
| Deferred Income Tax Assets |
11,971,799.20 |
| Other Non-Current Assets |
66,487,958.42 |
| Sub-Total of Non-Current Assets |
1,805,147,109.37 |
| Total Assets |
3,898,115,578.61 |
| Short-Term Loans |
1,117,515,399.32 |
| Trading Financial liabilities |
-- |
| Notes Payable |
23,767,975.47 |
| Accounts Payable |
382,930,197.90 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
43,109,439.27 |
| Taxes Payable |
36,692,344.48 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
468,094,880.55 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
14,459,981.90 |
| Other Current Liabilities |
79,293,321.58 |
| Sub-Total of Current Liabilities |
2,229,844,569.24 |
| Long-term Loans |
34,006,939.05 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
74,776,088.65 |
| Total Liabilities |
2,304,620,657.89 |
| Paid-In Capital(Or Share Stock) |
1,080,043,333.00 |
| Capital Surplus |
1,446,574,558.13 |
| Surplus Reserve |
253,993,951.66 |
| LESS:Treasury Stock |
149,267,195.76 |
| Undistributed Profits |
-1,103,958,717.49 |
| Minority Stockholder's Interest |
54,058,345.54 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,539,436,575.18 |
| Owner's Equity（Stockholder's Equity） |
1,593,494,920.72 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,898,115,578.61 |
